Status | Study |
NOT_YET_RECRUITING |
Study Name: Effectiveness of Educational Gamified Cards About Nephrotic Syndrome Condition: Date: 2023-05-27 Interventions: The study intervention "Spin to Win - Nephro Cards" will include the following items with simple Arabic language and graphic designa |
NOT_YET_RECRUITING |
Study Name: Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2022-10-26 Interventions: ADX-629 (250 milligrams) administered twice daily |
Recruiting |
Study Name: Super Chinese Nephrotic Syndrome Registration System (SUCCESS) Condition: Nephrotic Syndrome Date: 2016-12-21 Interventions: Other: No intervention Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen U |
Recruiting |
Study Name: Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2016-12-16 Interventions: Drug: Alirocumab 150 mg biweek |
Active, not recruiting |
Study Name: Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2016-03-30 Interventions: Drug: Acthar Gel and Tacrolimus Combination therapy with Acthar Gel and Tacrolimus (0.5-3.0 mg BID) foll |
Completed |
Study Name: IL-2 for Multi Drug Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-05-13 Interventions: Drug: Proleukin® Other Name: IL-2 |
Completed |
Study Name: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-05-06 Interventions: Drug: Tacrolimus Oral Tacrolim |
Recruiting |
Study Name: Ofatumumab in Children With Drug Resistant Idiopathic Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-06 Interventions: Drug: Ofatumumab Ofatumumab 15 |
Recruiting |
Study Name: Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor Dependent Idiopathic Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-06 Interventions: Drug: Ofatumumab 1500 mg/1.73m |
Recruiting |
Study Name: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome Condition: Nephrotic Syndrome Date: 2015-03-03 Interventions: Drug: Rituximab Two to four ri |